| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1918941 | Maturitas | 2006 | 4 Pages |
Abstract
It may be suggested that more aggressive clinically and frequently receptor-negative type II of endometrial cancer is associated with indirect signs of mainly intratumoral hyperproduction of estrogens (excess of CYP19 A6A6 genotype) without their sufficient inactivation into methoxyderivatives that warrants further study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Lev Berstein, Tatjana Zimarina, Evgeny Imyanitov, Anatolij Kovalevskij, Sergei Maximov, Pascal Pujol, Jos Thijssen,